These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 30207106)

  • 1. Performance of pre-treatment ¹⁸F-fluorodeoxyglucose positron emission tomography/computed tomography for detecting metastasis in ovarian cancer: a systematic review and meta-analysis.
    Han S; Woo S; Suh CH; Lee JJ
    J Gynecol Oncol; 2018 Nov; 29(6):e98. PubMed ID: 30207106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance of Positron Emission Tomography and Positron Emission Tomography/Computed Tomography Using Fluorine-18-Fluorodeoxyglucose for the Diagnosis, Staging, and Recurrence Assessment of Bone Sarcoma: A Systematic Review and Meta-Analysis.
    Liu F; Zhang Q; Zhu D; Liu F; Li Z; Li J; Wang B; Zhou D; Dong J
    Medicine (Baltimore); 2015 Sep; 94(36):e1462. PubMed ID: 26356700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A systematic review and meta-analysis of
    Kim SJ; Lee SW; Jeong SY; Pak K; Kim K
    J Vasc Surg; 2019 Jul; 70(1):307-313. PubMed ID: 30922755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic role of F-18 FDG PET/CT for preoperative lymph node staging in thyroid cancer patients; A systematic review and metaanalysis.
    Kim DH; Kim SJ
    Clin Imaging; 2020 Sep; 65():100-107. PubMed ID: 32387798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of magnetic resonance imaging and 18-fludeoxyglucose positron emission tomography/computed tomography in the diagnostic accuracy of staging in patients with cholangiocarcinoma: A meta-analysis.
    Huang X; Yang J; Li J; Xiong Y
    Medicine (Baltimore); 2020 Aug; 99(35):e20932. PubMed ID: 32871859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 18 F-fluorodeoxyglucose positron emission tomography to evaluate recurrent gastric cancer: a systematic review and meta-analysis.
    Wu LM; Hu JN; Hua J; Gu HY; Zhu J; Xu JR
    J Gastroenterol Hepatol; 2012 Mar; 27(3):472-80. PubMed ID: 21916986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of 18F-Fluorodeoxyglucose Positron Emission Tomography or Positron Emission Tomography/Computed Tomography for the Detection of Recurrent Disease after Treatment of Malignant Melanoma.
    Lee JW; Nam SB; Kim SJ
    Oncology; 2019; 97(5):286-293. PubMed ID: 31437839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic performance of whole-body [
    Mirshahvalad SA; Kohan A; Metser U; Hinzpeter R; Ortega C; Farag A; Veit-Haibach P
    Eur Radiol; 2024 Jan; 34(1):673-685. PubMed ID: 37535156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic value of integrated ¹⁸F-fluoro-2-deoxyglucose positron emission tomography/computed tomography in recurrent epithelial ovarian cancer: accuracy of patient selection for secondary cytoreduction in 134 patients.
    Lee YJ; Kim YM; Jung PS; Lee JJ; Kim JK; Kim YT; Nam JH
    J Gynecol Oncol; 2018 May; 29(3):e36. PubMed ID: 29400023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic value of fluorine 18 fluorodeoxyglucose positron emission tomography/computed tomography for the detection of metastases in non-small-cell lung cancer patients.
    Wu Y; Li P; Zhang H; Shi Y; Wu H; Zhang J; Qian Y; Li C; Yang J
    Int J Cancer; 2013 Jan; 132(2):E37-47. PubMed ID: 22890912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Staging/restaging performance of F18-fluorodeoxyglucose positron emission tomography/magnetic resonance imaging in breast cancer: A review and meta-analysis.
    Lin CY; Lin CL; Kao CH
    Eur J Radiol; 2018 Oct; 107():158-165. PubMed ID: 30292261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance of F-18 FDG PET/CT for predicting malignant potential of gastrointestinal stromal tumors: A systematic review and meta-analysis.
    Kim SJ; Lee SW
    J Gastroenterol Hepatol; 2018 Mar; 33(3):576-582. PubMed ID: 28994187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic Performance of F-18 Fluorodeoxyglucose Positron Emission Tomography or Positron Emission Tomography/Computed Tomography for Differentiation of Benign and Malignant Vertebral Compression Fractures: A Meta-Analysis.
    Kim SJ; Lee JS
    World Neurosurg; 2020 May; 137():e626-e633. PubMed ID: 32105873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic accuracy of
    Kim SJ; Lee SW
    Br J Radiol; 2018 Jan; 91(1081):20170519. PubMed ID: 29099613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A two-way comparison of whole-body 18FDG PET-CT and whole-body contrast-enhanced MRI for distant metastasis staging in patients with malignant tumors: a meta-analysis of 13 prospective studies.
    Li J; Zhou H; Zhang X; Song F; Pang X; Wei Z
    Ann Palliat Med; 2020 Mar; 9(2):247-255. PubMed ID: 32233618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluorine-18-fluorodeoxyglucose positron emission tomography to evaluate recurrent gastric cancer after surgical resection: a systematic review and meta-analysis.
    Li P; Liu Q; Wang C; Wang T; Liu J; Huang G; Song S
    Ann Nucl Med; 2016 Apr; 30(3):179-87. PubMed ID: 26830546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Positron emission tomography (PET) and magnetic resonance imaging (MRI) for assessing tumour resectability in advanced epithelial ovarian/fallopian tube/primary peritoneal cancer.
    Roze JF; Hoogendam JP; van de Wetering FT; Spijker R; Verleye L; Vlayen J; Veldhuis WB; Scholten RJ; Zweemer RP
    Cochrane Database Syst Rev; 2018 Oct; 10(10):CD012567. PubMed ID: 30298516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Indirect comparison of the diagnostic performance of
    Hu X; Li D; Liang Z; Liao Y; Yang L; Wang R; Wang P; Cai J
    BMC Cancer; 2021 Oct; 21(1):1080. PubMed ID: 34615498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic Accuracy of F-18 FDG PET/CT for Preoperative Lymph Node Staging in Newly Diagnosed Bladder Cancer Patients: A Systematic Review and Meta-Analysis.
    Ha HK; Koo PJ; Kim SJ
    Oncology; 2018; 95(1):31-38. PubMed ID: 29847834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Whole-body
    Gajjala SR; Hulikal N; Kadiyala S; Kottu R; Kalawat T
    Indian J Med Res; 2018 Mar; 147(3):256-262. PubMed ID: 29923514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.